Whole genome sequencing to help you improve your health and longevity. $999. U.S. price.
A simple screening test to help you understand your risk for hereditary breast and ovarian cancer.
Screening test of 26 genes, including BRCA1 and BRCA2, for increased risk of developing breast, ovarian, and other inherited cancers.
Maternal blood-based non-invasive screening that predicts the presence of Down Syndrome (T21), Edwards Syndrome (T18), and Patau Syndrome (T13).
Saliva-based screening of prospective or currently pregnant parents to see if they carry inherited and rare conditions such as cystic fibrosis.
Comprehensive genetic screening of newborns for early childhood diseases.
Industry-leading genetic tests, whole genome sequencing, and interpretation for your patients.
Customized, fully integrated, research-only whole genome sequencing services.
Industry-leading genetic tests and genome sequencing solutions.
Your genome is your complete set of DNA - and it is 6 billion letters long (A, T, C, Gs). Sequencing your whole genome, as opposed to only looking at a small part of your genome, matters because:
<1 million DNA letters (bases)
~0.02% of the genome
~50 million DNA letters (bases)
~1.5% of the genome
6 billion DNA letters (bases)
6 billion DNAletters
90% of the important DNA elements are outside of the coding region of the genome. You can only access these with whole genome sequencing.
...have a genetic susceptibility to dangers of dietary iron excess, which predisposes them to significantly higher risk of serious diseases including Alzheimerʼs.
By sequencing your whole genome, we can identify the genetic variants associated with these risks and can therefore guide you to dietary modifications to mitigate these risks as well as proper therapeutic interventions, if necessary.
Variants in HFE are associated with a condition called hereditary hemochromatosis. You carry one “non-working” gene, which means that your body might not regulate intake of the iron in your food appropriately. If so, you might need to assess your consumption of iron-rich foods and adjust your diet.
While a proper balance of Omega-6 and Omega-3 fatty acids is associated with a reduced risk of heart disease, your genetics have a key role to play in your ability to absorb these fatty acids.
Responses to Omega-6 and Omega-3 fats (FADS1 c.1248+52A>G)You may consider increasing your consumption of Omega-3 and Omega-6 fats through diet or supplements. We also recommend you discuss this further with your healthcare provider.
Proper balance of Omega-6 and Omega-3 fatty acids is associated with a reduced risk of heart disease. Lower total cholesterol, lower LDL (“bad”) cholesterol, and higher HDL (often referred to as “good”) cholesterol are also associated with a reduced cancer risk. Very high consumption of Omega-6 and 3 fats is associated with certain health problems.
but knowing what genetic conditions you and your partner carry can help you understand the risks and plan better. Learn if you are a carrier of a genetic condition and what you could pass on to your children. In addition, our genetic counselors will help you understand your results, for example;
You carry one ‘non-workingʼ gene for PKU (also known as PAH deficiency). Carriers do not show or develop symptoms of PKU, however if you are planning a family, this variant can be passed down to your children. Since PKU affects children who have 2 ‘non-workingʼ copies of the PAH gene, pregnancies are only at risk when both parents are carriers.
Genetic testing for your partner and other relatives may be considered and should be discussed with your healthcare provider and/or genetic counselor.
Our bodies may metabolize and respond to drugs differently due to our genetics. This is called pharmacogenomics. myGenome provides insights on how you may respond to over 200 drugs.
Simvastatin (trade name Zocor) is a drug used to treat high cholesterol and triglyceride levels. Based on your CC genotype for the SLC01B1 gene, you may require a dosage change. Please consult your doctor before making any dosage changes.